• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6例接受溴隐亭治疗的帕金森病患者生长激素和催乳素的昼夜变化(作者译)

[Nycterohemeral variations of growth hormone and prolactin in 6 Parkinson's sufferers treated with bromocriptine (author's transl)].

作者信息

Passouant P, Besset A, Descomps B, Bonardet A, Billiard M, Nègre C

出版信息

Nouv Presse Med. 1979 Oct 22;8(40):3237-42.

PMID:534183
Abstract

Secretions of GH and of PRL studied over a period of 24 hours in 6 untreated Parkinson's patients showed slight changes. The normal secretion of PRL in the female shows no nocturnal increase in the male. The secretion of GH linked to sleep is identified in the male and not in the female. These variations related to sex are interpreted as an increase in those normally found in the adult and facilitated by age. Bromocriptine given continuously at a dose of 10 to 20 mg/day for periods of 20 days to 6 months, results in suppression or a marked decrease in the 24-hour secretion of PRL. It has virtually no effect upon the secretion of GH. These results show that the dopaminergic regulation of PRL is preserved in Parkinson's disease.

摘要

在6名未经治疗的帕金森病患者中,对生长激素(GH)和催乳素(PRL)进行了24小时的分泌研究,结果显示有轻微变化。女性PRL的正常分泌在男性中无夜间增加。与睡眠相关的GH分泌在男性中可检测到,而在女性中则不然。这些与性别相关的差异被解释为成人中常见的增加,并随着年龄增长而加剧。以10至20毫克/天的剂量持续给予溴隐亭20天至6个月,可导致PRL的24小时分泌受到抑制或显著减少。它对GH的分泌几乎没有影响。这些结果表明,帕金森病中PRL的多巴胺能调节功能得以保留。

相似文献

1
[Nycterohemeral variations of growth hormone and prolactin in 6 Parkinson's sufferers treated with bromocriptine (author's transl)].6例接受溴隐亭治疗的帕金森病患者生长激素和催乳素的昼夜变化(作者译)
Nouv Presse Med. 1979 Oct 22;8(40):3237-42.
2
Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
J Clin Endocrinol Metab. 1978 Oct;47(4):807-11. doi: 10.1210/jcem-47-4-807.
3
[Sleep-waking cycle and the nyctohemeral secretion of prolactin and somatotropin in Parkinson patients. Effect of bromocriptine].[帕金森病患者的睡眠-觉醒周期以及催乳素和生长激素的昼夜分泌。溴隐亭的作用]
Bull Acad Natl Med. 1980 Feb;164(2):134-8.
4
Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.麦角生物碱对人体生长激素和催乳素分泌的影响。
Pharmacology. 1978;16 Suppl 1:78-87. doi: 10.1159/000136810.
5
Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response.
J Neural Transm. 1981;51(1-2):123-34. doi: 10.1007/BF01664010.
6
The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
J Endocrinol Invest. 1980 Oct-Dec;3(4):343-7. doi: 10.1007/BF03349368.
7
Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.肢端肥大症患者中,纯生长激素(GH)垂体腺瘤和生长激素/催乳素混合垂体腺瘤对胍法辛、溴隐亭和促甲状腺激素释放激素的生长激素分泌反应不同。
J Clin Endocrinol Metab. 1985 Jun;60(6):1148-53. doi: 10.1210/jcem-60-6-1148.
8
Circadian rhythmicity of prolactin secretion in elderly subjects: changes during bromocriptine treatment.
J Endocrinol Invest. 1981 Jul-Sep;4(3):317-21. doi: 10.1007/BF03349450.
9
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.儿茶酚胺、促甲状腺激素释放激素和生长抑素对培养的人垂体腺瘤细胞和非腺瘤细胞生长激素及催乳素分泌的直接影响。
J Clin Invest. 1984 Jan;73(1):66-78. doi: 10.1172/JCI111208.
10
Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine.用溴隐亭治疗的帕金森病患者的血浆垂体激素
J Neural Transm. 1978;42(2):151-7. doi: 10.1007/BF01675354.